MarginsXMarginsX
Home › Markets › Health Care › MTNB

Matinas Biopharma Holdings Inc. (MTNB)

MTNB trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.9270
+3.00% on the day
Market cap
$908K
Nano cap
Revenue · 2023
$1.1M
-65.6% on 2022
Net income · 2023
-$22.9M
-2093.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2023-12-31, https://www.sec.gov/Archives/edgar/data/1582554/000164117225004882/0001641172-25-004882-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2023-12-31.

Profile

FieldValue
TickerMTNB on NYSE
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2017
SEC CIK0001582554
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2023

LineValue
Revenue$1.1M
Net income-$22.9M
Operating income-$23.8M
Net margin-2093.2%
Operating margin-2168.4%
Revenue growth-65.6%
Cash$4.8M
Total assets$25.1M
P/E (computed)Net income was not positive
P/S (computed)0.8×

Warning signs

Cash runway
1.4 months
$761K cash at June 30, 2026
Share count, 1 year
+188.8%
2025-08-12 to 2026-08-10 · +238.1% over 3 years
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, substantial doubt exists about the Company's ability to continue as a going concern."
10-Q 2026-08-13
Cash and burn$761K cash; operating cash flow -$1.6M a quarter.Report 2026-06-30
Shares outstanding979,520 (2026-08-10); 5,086,985 a year earlier; 217,264,526 three years earlier. 3y figure adjusted for splits (1-for-50 overall).Cover page 2026-08-10
Reverse splits, 3 years2; latest 1-for-15 on 2026-09-28Source 2026-09-28
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-06-16
Exchange deficiency notices, 12 months3 (8-K item 3.01)8-K 2026-09-04
AuditorEisnerAmper LLP, Iselin, New Jersey, United StatesPCAOB Form AP 2026-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$1.3M-$1.8M$761KNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$1.9M-$1.6M$2.4MNo debt tagsNeeds four quarters10-Q 2026-05-08
Q4 2025
2025-12-31
Not filed-$1.9M-$1.5M$4.0MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$1.5M-$1.5M$5.4MNo debt tagsNeeds four quarters10-Q 2025-11-10
Q2 2025
2025-06-30
Not filed-$5.2M-$2.0M$6.5MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$1.7M-$2.0M$6.9MNo debt tagsNeeds four quarters10-Q 2026-05-08
Q4 2024
2024-12-31
Not filed-$8.4M-$3.5M$7.3MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2024
2024-09-30
Not filed-$4.3M-$3.5M$10.3MNo debt tagsNeeds four quarters10-Q 2025-11-10

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B72026-06-22
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-03
Latest proxyDEF 14A2025-05-12

Source: SEC EDGAR submissions feed, 577 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-24.4%
1 month-64.0%
3 months-74.2%
Year to date+53.6%
1 year-25.6%
From 52-week high-93.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
OGENOragenics Inc.$0.1980-1.49%$893K
SPRCSciSparc Ltd.$0.3307-10.62%$815K
GOVXGeoVax Labs Inc.$2.02+18.48%$1.1M
BDRXBiodexa Pharmaceuticals plc American Depositary Shs$2.24-6.28%$1.2M
ELABPMGC Holdings Inc.$1.66+5.06%$1.3M
KAPAKairos Pharma Ltd.$0.4069-10.30%$1.4M
APVOAptevo Therapeutics Inc.$0.5486-7.66%$1.5M
LABTLakewood-Amedex Biotherapeutics Inc.$0.2194-22.31%$520K

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier